Coronary Stent Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Drug-Eluting Stent, Bioresorbable Stent, Bare Metal Stent, Covered Stent, and Others), By Mode of Delivery (Self-expandable and Balloon-expandable), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, and Others) and Region 

Coronary Stent Market size was valued at US$ 8,923.2 million in 2023 and is poised to grow at a significant CAGR of 3.6% from 2024–2030. Coronary stents (CS) are expandable tubular metallic devices that are used to widen blocked or narrowed coronary arteries that are clogged due to an underlying atherosclerosis disease. This revascularization procedure is termed a percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement. A coronary angioplasty is a procedure. The term "angioplasty" means using a balloon to stretch open a narrowed or blocked artery.

However, most modern angioplasty procedures also involve inserting a short wire-mesh tube, called a stent, into the artery during the procedure. These arteries can become narrowed and hardened in older people, which can cause coronary heart disease. Coronary angioplasties are also often used as an emergency treatment after a heart attack or angina. Increasing technological advancement, rising incidence of coronary artery disease, the subsequent growth in the number of PCI procedures, increasing demand for minimally invasive procedures, and rising geriatric population are driving the global market growth. The increasing prevalence of cardiovascular drugs diseases is boosting the market trend at a significant rate.

For instance, according to the Centers for Disease Control and Prevention (CDC), coronary heart disease, the most common type of heart disease, killed 382,820 people in 2020 in the USA and about 20.1 million adults age 20 and older had CAD (about 7.2%). Along with that emerging global markets and global players are influencing the growth. However, the availability of alternative treatment methods for coronary artery diseases, stringent regulations for product approval, and the increasing number of product failures, and product recalls may hamper the global coronary stent market growth. Geographically, North America held the major market share in the global market and is expected to dominate the market in the forecasted years.

Key Developments

• In Aug 2022, Medtronic launched its Onyx Frontier drug-eluting stent (DES), a new interventional offering for coronary artery disease (CAD). In May 2022, Abbott announced that its Xience Skypoint drug-eluting stent platform is now available globally.